Oral fluoropyrimidine-induced severe hyperlipidemia

Asian Biomedicine

Volumn 4, Issue 4, 2010, Pages 627-630

  Yildiz, Bulent ^a   Kavgaci, Halil ^a   Fidan, Evren ^a   Gungor, Erdal ^a   Ersoz, Halil O ^a   Ozdemir, Feyyaz ^a   Aydin, Fazil ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Adverse event; Capecitabine; Drug; Hypertriglyceridemia; Oral fluoropyrimidine; UFT reg

Indexed keywords

CAPECITABINE; CETUXIMAB; CHOLESTEROL; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; GEMFIBROZIL; IRINOTECAN; OXALIPLATIN; TRIACYLGLYCEROL; UFT;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHOLESTEROL BLOOD LEVEL; COLORECTAL CANCER; DISEASE COURSE; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; MALE; MULTIPLE CYCLE TREATMENT; RECTUM CANCER; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77957957446     PISSN: 19057415     EISSN: None     Source Type: Journal    
DOI: 10.2478/abm-2010-0079     Document Type: Article

References (7)

1. Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, et al. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2002; 20:3617-27
2. Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol. 2001; 19:4097-106
3. Bar-Sela G, Haim N. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature. Cancer Chemother Pharmacol. 2009; 63: 779-82
4. Stathopoulos G P, Koutantos J, Lazaki H, Rigatos SK, Stathopoulos J, Deliconstantinos G. The marked words were removed. Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects. Anticancer Res. 2007; 27: 1653-6
5. Koutras AK, Habeos IG, Vagenakis AG, Kalofonos HP. Capecitabine-induced hypertriglyceridemia: a report of two cases. Anticancer Res. 2006; 26: 2249-51
6. Kurt M, Babaoglu MO, Yasar U, Shorbagi A, Guler N. Capecitabine-induced severe hypertriglyceridemia: report of two cases. Ann Pharmacother. 2006; 40: 328-31
7. Stathopoulos GP, Stergiou GS, Perrea-Kostarelis DN, Dontas IA, Karamanos BG, Karayiannacos PE. Influence of 5-fluorouracil on serum lipids. Acta Oncol. 1995; 34:253-6